Loading...
S

Sema4 Holdings Corp
NASDAQ:SMFR

Watchlist Manager
Sema4 Holdings Corp
NASDAQ:SMFR
Watchlist
Price: 0.27 USD -12.9% Market Closed
Updated: Dec 10, 2022

Intrinsic Value

The intrinsic value of one SMFR stock under the Base Case scenario is 1.62 USD. Compared to the current market price of 0.27 USD, Sema4 Holdings Corp is Undervalued by 83%.

The Intrinsic Value is calculated as the average of the two valuation methods:

SMFR Intrinsic Value
Base Case
1.62 USD
Undervaluation 83%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Fundamental Analysis

SMFR Profitability Score
Profitability Due Diligence

Sema4 Holdings Corp's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative 3-Year Average ROIC
Negative Free Cash Flow
Negative Gross Profit
18/100
Profitability
Score

Sema4 Holdings Corp's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

SMFR Solvency Score
Solvency Due Diligence

Sema4 Holdings Corp's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Low Altman Z-Score
Short-Term Liabilities
Long-Term Liabilities
48/100
Solvency
Score

Sema4 Holdings Corp's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
-1%
Gross Margin
-198%
Operating Margin
-121%
Net Margin
-141%
FCF Margin
-59%
ROE
-106%
ROIC
Other

SMFR Capital Structure
Sema4 Holdings Corp

Market Capitalization 103M USD
Total Debt 55.8M USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 191M USD
Short-Term Investments 0 USD
Enterprise Value -32.6M USD

Wall St
Price Targets

SMFR Price Targets Summary
Sema4 Holdings Corp

Wall Street analysts forecast SMFR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMFR is 2.25 USD .

Lowest
Price Target
Not Available
Average
Price Target
2.25 USD
733% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

SMFR Competitors
Sema4 Holdings Corp

SMFR Suppliers & Customers
Sema4 Holdings Corp

Sema4 Holdings Corp has 11 key suppliers from 3 countries and 6 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Life Sciences Tools & Services industry.

Sema4 Holdings Corp has 5 key customers from 3 countries and 3 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Biotechnology industry.

Ownership

SMFR Insider Trading
Buy and sell transactions by insiders

Sema4 Holdings Corp insiders have bought more shares than they have sold in the past 12 months.

During the last 12 months Sema4 Holdings Corp insiders bought 274M USD , and sold 6.3M USD worth of shares. The last transaction was made on Dec 10, 2022 by Feeley Kevin (Chief Financial Officer), who sold 6.7k USD worth of SMFR shares.

Sold
0-3
months
5.4M USD
5
3-6
months
121k USD
6
6-9
months
321k USD
7
9-12
months
417k USD
7
Bought
0-3
months
1
200k USD
3-6
months
0
0 USD
6-9
months
6
273M USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
5.4M USD
200k USD
-5.2M
6 Months
5.6M USD
200k USD
-5.4M
9 Months
5.9M USD
274M USD
268M
12 Months
6.3M USD
274M USD
267M
Purchases
7
Sales
38
Why is insider trading important?

Shareholder Return

SMFR Price
Sema4 Holdings Corp

1M 1M
-71%
6M 6M
-83%
1Y 1Y
-95%
3Y 3Y
-97%
5Y 5Y
-97%
Annual Price Range
0.27
52w Low
0.27
52w High
5.17
Price Metrics
Average Annual Return 9.69%
Standard Deviation of Annual Returns
N/A
Max Drawdown -99%
Shares Statistics
Market Capitalization 103M USD
Shares Outstanding 380 641 984
Percentage of Shares Shorted 3.87%

Company Profile

Sema4 Holdings Corp

Country

United States of America

Industry

Health Care

Market Cap

103M USD

Dividend Yield

0%

Description

Sema4 Holdings Corp.is a patient centered health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,200 full-time employees. The company went IPO on 2020-09-04. The firm applies artificial intelligence and machine learning to clinical and genomic data to build models of human health and define individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate a complete understanding of disease and wellness and to provide science-driven solutions to pressing medical needs. Its Expanded Carrier Screen (ECS) is a carrier screen for inherited conditions. Its Noninvasive Prenatal Testing Solutions is a test that screens for autosomal and sex chromosome aneuploidies. Its Natalis Newborn Screening Solutions is a test of its screening portfolio allowing for detection of heritable conditions from pre-conception, pregnancy and childhood. The firm also includes Signal Precision Oncology Solutions.

Contact

CONNECTICUT
Stamford
333 Ludlow Street, North Tower, 8Th Floor
+16177808742.0
https://sema4.com/

IPO

2020-09-04

Employees

1 200

Officers

Exec. Chair of the Board
Mr. Jason Ryan
Consultant
Mr. Isaac Ro
CEO & Director
Ms. Katherine A. Stueland
Sr. VP of Operations & CFO
Mr. Kevin Feeley
VP of Technology Devel.
Mr. Robert Sebra Ph.D.
Chief Technology & Product Officer
Dr. Matthew Davis Ph.D.
Show More
Chief Science Officer
Dr. Gustavo Stolovitzky Ph.D.
Chief Compliance & Privacy Officer
Mr. Murali Mani
VP of Fin. & Corp. Devel.
Mr. Joel Harrison Kaufman
Chief People Officer
Ms. Karen White
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one SMFR stock?

The intrinsic value of one SMFR stock under the Base Case scenario is 1.62 USD.

Is SMFR stock undervalued or overvalued?

Compared to the current market price of 0.27 USD, Sema4 Holdings Corp is Undervalued by 83%.